Answers are grounded in this paper and cite their sources.
We here describe differences in the postsurgery inflammatory profiles of existing and potential vitreous substitutes. Bio-Alcamid® and silicone oil display severe signs of gliosis and inflammation, whereas Healaflow® elicits minimal reactions comparable with BSS, highlighting its potential application as a vitreous substitute in a future clinical setting.
No takes yet. Share an insight, caveat, or question.
Barth et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: